Market Cap 3.80B
Revenue (ttm) 258.22M
Net Income (ttm) -28.24M
EPS (ttm) N/A
PE Ratio 40.17
Forward PE 23.46
Profit Margin -10.94%
Debt to Equity Ratio 0.44
Volume 2,017,100
Avg Vol 2,300,354
Day's Range N/A - N/A
Shares Out 236.39M
Stochastic %K 30%
Beta 0.75
Analysts Strong Sell
Price Target $26.00

Latest News on ADMA

ADMA Biologics, Inc. (ADMA) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 10:12 PM EST - 3 months ago

ADMA Biologics, Inc. (ADMA) Q3 2024 Earnings Call Transcript